Structure Therapeutics Inc.
Structure Therapeutics Inc. (GPCR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GPCR · as of Jun 8, 2026
Key Statistics
Explore Structure Therapeutics Inc. Data
gpcr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 100.0%
The GPCR analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $114.75, representing +203.81% upside from the current price of $37.77.
Competitors & Peers
gpcr competitorsGPCR
ABCL
CLDX
EWTX
GLPG
LQDAStock Performance
Full HistoryAbout Structure Therapeutics Inc.
Structure Therapeutics Inc. an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various ch…
what is structure therapeutics inc. · gpcr stock overview · structure therapeutics inc. company profile · who is structure therapeutics inc. ceo · gpcr NASDAQ · structure therapeutics inc. headquarters · structure therapeutics inc. business segments
About Stock Overview & Key Data
Structure Therapeutics Inc. (GPCR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 3, 2023. As of the latest trading session, GPCR stock price is $37.77, with a market capitalization of $2.2B. The stock has returned +82.94% over the past 12 months and -46.05% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Structure Therapeutics Inc. stock is Buy, with an average 12-month price target of $114.75. In fiscal year 2025, Structure Therapeutics Inc. reported revenue of — and net income of -$141.2M. For detailed data — including Structure Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Structure Therapeutics Inc. (GPCR) stock price is $37.77. The stock is traded on NASDAQ under the ticker symbol GPCR. The 52-week range is $15.80 – $94.90.